Remission of systemic arterial hypertension, type II Diabetes mellitus and dyslipidemia after bariatric surgery: a longitudinal study




Gastroplasty; Bariatric Surgery; Diabetes Mellitus; Hypertension.


Reductive gastroplasty, also known as bariatric surgery, is recommended for patients with body mass index (BMI) > 40 kg/m2, regardless of the presence of comorbidities and BMI between 35 and 40kg/m2 if associated diseases presented. Bariatric surgeries can be divided into restrictive or mixed. The restrictive ones occur when only the stomach is modified. In mixed surgeries, there is a change in patient´s intestine and stomach. Both operations reduce the patient´s weight. This study sought to assess the remission of diseases such as systemic arterial hypertension, type two diabetes mellitus and dyslipidemia within five years after the operation and after this period in 53 patients of a gastroenterology clinic in west Parana. A reduction in the prevalence of all three studied pathologies was observed in the period up to five years after the operation (p<0,001) and after five years (p<0,001). Therefore, the effectiveness of bariatric surgery in reduction of the prevalence of diseases resulting from obesity is evident.


Affinati, A. H., Esfandiari, N. H., Oral, E. A., & Kraftson, A. T. (2019). Bariatric surgery versus medications in the treatment of type 2 diabetes. Current Diabetes Reports, 19(156), 1–10.

Arterburn, D. E., Telem, D. A., Kushner, R. F., & Courcoulas, A. P. (2020). Benefits and Risks of Bariatric Surgery in Adults: A Review. JAMA - Journal of the American Medical Association, 324(9), 879–887.

Balsiger, B. M., Kennedy, F. P., Abu-Lebdeh, H. S., Collazo-Clavell, M., Jensen, M. D., O’Brien, T., Hensrud, D. D., Dinneen, S. F., Thompson, G. B., Que, F. G., Williams, D. E., Clark, M. M., Grant, J. E., Frick, M. S., Mueller, R. A., Mai, J. L., & Sarr, M. G. (2000). Prospective Evaluation of Roux-en-Y Gastric Bypass as Primary Operation for Medically Complicated Obesity. Mayo Clinic Proceedings, 75(7), 673–680.

Cardoso, L., Rodrigues, D., Gomes, L., & Carrilho, F. (2017). Short- and long-term mortality after bariatric surgery: A systematic review and meta-analysis. Diabetes, Obesity and Metabolism, 19(9), 1223–1232.

Carvalho, A. da S., & Rosa, R. D. S. (2019). Cirurgias bariátricas realizadas pelo Sistema Único de Saúde no período 2010-2016: estudo descritivo das hospitalizações no Brasil. Epidemiologia e Servicos de Saude : Revista Do Sistema Unico de Saude Do Brasil, 28(1), e2018260.

Chikunguwo, S. M., Wolfe, L. G., Dodson, P., Meador, J. G., Baugh, N., Clore, J. N., Kellum, J. M., & Maher, J. W. (2010). Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass. Surgery for Obesity and Related Diseases, 6(3), 254–259.

Chung, A. Y., Thompson, R., Overby, D. W., Duke, M. C., & Farrell, T. M. (2018). Sleeve Gastrectomy: Surgical Tips. Journal of Laparoendoscopic and Advanced Surgical Techniques, 28(8), 930–937.

Coleman, K. J., Haneuse, S., Johnson, E., Bogart, A., Fisher, D., O’Connor, P. J., Sherwood, N. E., Sidney, S., Theis, M. K., Anau, J., Schroeder, E. B., O’Brien, R., & Arterburn, D. (2016). Long-term microvascular disease outcomes in patients with type 2 diabetes after bariatric surgery: Evidence for the legacy effect of surgery. Diabetes Care, 39(8), 1400–1407.

Cooiman, M., Mol, B., Aarts, E., Janssen, I., Hazebroek, E., & Berends, F. (2019). Weight loss, reduction of comorbidities and quality of life after bariatric surgery in the elderly. Obesity Surgery, 29(6), 1851–1857.

Cordero, P., Li, J., & Oben, J. A. (2017). Bariatric surgery as a treatment for metabolic syndrome. Journal of the Royal College of Physicians of Edinburgh, 47(4), 364–368.

Hydock, C. M. (2005). A brief overview of bariatric surgical procedures currently being used to treat the obese patient. Critical Care Nursing Quarterly, 28(3), 217–226.

Jung, U. J., & Choi, M. S. (2014). Obesity and its metabolic complications: The role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. International Journal of Molecular Sciences, 15(4), 6184–6223.

Kalita, S., Khandelwal, S., Madan, J., Pandya, H., Sesikeran, B., & Krishnaswamy, K. (2018). Almonds and cardiovascular health: A review. Nutrients, 10(4), 1–10.

Kopin, L., & Lowenstein, C. J. (2017). Dyslipidemia. Annals of Internal Medicine, 167(11), ITC81–ITC96.

Maggard, M. A., Shugarman, L. R., Suttorp, M., Maglione, M., Sugarman, H. J., Livingston, E. H., Nguyen, N. T., Li, Z., Mojica, W. A., Hilton, L., & Rhodes, S. (2005). Clinical Guidelines Meta-Analysis: Surgical Treatment of Obesity. Annals of Internal Medicine.

Maggard-Gibbons, M. A., Maglione, M., Livhits, M., Ewing, B., Maher, A. R., Hu, J., Li, Z., & Shekelle, P. G. (2013). Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes a systematic review. JAMA - Journal of the American Medical Association, 309(21), 2250–2261.

Marcelino, L. F., & Patrício, Z. M. (2011). The complexity of obesity and life after bariatric surgery: A public health issue. Ciencia e Saude Coletiva, 16(12), 4767–4776.

O’Brien, P. E., Hindle, A., Brennan, L., Skinner, S., Burton, P., Smith, A., Crosthwaite, G., & Brown, W. (2018). Long-Term Outcomes After Bariatric Surgery: a Systematic Review and Meta-analysis of Weight Loss at 10 or More Years for All Bariatric Procedures and a Single-Centre Review of 20-Year Outcomes After Adjustable Gastric Banding. Obesity Surgery, 29(1), 3–14.

Pereira A. S. et al. (2018). Metodologia da pesquisa científica. [free e-book]. Santa Maria. Ed. UAB/NTE/UFSM

Schiavon, C. A., Bersch-Ferreira, A. C., Santucci, E. V., Oliveira, J. D., Torreglosa, C. R., Bueno, P. T., Frayha, J. C., Santos, R. N., Damiani, L. P., Noujaim, P. M., Halpern, H., Monteiro, F. L. J., Cohen, R. V., Uchoa, C. H., De Souza, M. G., Amodeo, C., Bortolotto, L., Ikeoka, D., Drager, L. F., … Berwanger, O. (2018). Effects of bariatric surgery in obese patients with hypertension the GATEWAY randomized trial (gastric bypass to treat obese patients with steady hypertension). Circulation, 137(11), 1132–1142.

Sheng, B., Truong, K., Spitler, H., Zhang, L., Tong, X., & Chen, L. (2017). The Long-Term Effects of Bariatric Surgery on Type 2 Diabetes Remission, Microvascular and Macrovascular Complications, and Mortality: a Systematic Review and Meta-Analysis. Obesity Surgery, 27(10), 2724–2732.

Sjöström, C. D., Lissner, L., Wedel, H., & Sjöström, L. (1999). Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: The SOS intervention study. Obesity Research, 7(5), 477–484.

Sjostrom, L., Narbro, K., Sjostrom, D., Karason, K., Larsson, B., Wedel, H., & Lystig, T. (2007). Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects. The New England Journal of Medicine, 357(8), 741–752.

Wiggins, T., Guidozzi, N., Welbourn, R., Ahmed, A. R., & Markar, S. R. (2020). Association of bariatric surgery with all-cause mortality and incidence of obesity-related disease at a population level: A systematic review and meta-analysis. PLoS Medicine, 17(7), 1–18.

Wolfe, B. M., Kvach, E., & Eckel, R. H. (2016). Treatment of obesity. Circulation Research, 118(11), 1844–1855.

Zeve, J. L. de M., Novais, P. O., & Júnior, N. D. O. (2012). Técnicas em cirurgia bariátrica: uma revisão da literatura. Ciência & Saúde, 5(2), 132.



How to Cite

RECH, A. C.; MATSUMOTO, H. M. . Remission of systemic arterial hypertension, type II Diabetes mellitus and dyslipidemia after bariatric surgery: a longitudinal study. Research, Society and Development, [S. l.], v. 10, n. 12, p. e335101220390, 2021. DOI: 10.33448/rsd-v10i12.20390. Disponível em: Acesso em: 13 apr. 2024.



Health Sciences